GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $3.01 $4.17 Friday, 19th Apr 2024 CLRB stock ended at $3.03. This is 0.329% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.98% from a day low at $3.01 to a day high of $3.16.
90 days $3.01 $4.45
52 weeks $1.33 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
2023-10-19 $2.72 $2.73 $2.55 $2.63 102 523
2023-10-18 $2.70 $2.74 $2.62 $2.65 48 301
2023-10-17 $2.78 $2.85 $2.65 $2.73 114 647
2023-10-16 $2.56 $2.87 $2.55 $2.76 165 342
2023-10-13 $2.65 $2.74 $2.56 $2.59 39 764
2023-10-12 $2.60 $2.74 $2.52 $2.69 71 472
2023-10-11 $2.77 $2.83 $2.60 $2.62 77 525
2023-10-10 $2.73 $2.84 $2.69 $2.78 125 773
2023-10-09 $2.90 $2.90 $2.65 $2.77 102 343
2023-10-06 $2.85 $2.99 $2.79 $2.90 104 781
2023-10-05 $2.93 $2.98 $2.73 $2.85 193 648
2023-10-04 $2.76 $2.96 $2.72 $2.91 117 055
2023-10-03 $2.81 $3.00 $2.61 $2.78 208 670
2023-10-02 $2.75 $3.15 $2.70 $2.86 565 329
2023-09-29 $2.56 $2.77 $2.52 $2.64 189 701
2023-09-28 $2.53 $2.59 $2.50 $2.54 144 443
2023-09-27 $2.50 $2.64 $2.42 $2.54 216 180
2023-09-26 $2.48 $2.75 $2.41 $2.48 211 514
2023-09-25 $2.53 $2.75 $2.35 $2.45 313 885
2023-09-22 $2.22 $2.68 $2.18 $2.51 525 881
2023-09-21 $2.04 $2.25 $2.00 $2.19 235 891
2023-09-20 $2.07 $2.12 $2.03 $2.05 82 833
2023-09-19 $2.06 $2.17 $2.06 $2.10 223 010
2023-09-18 $2.20 $2.25 $2.02 $2.12 371 525
2023-09-15 $2.03 $2.21 $2.03 $2.21 67 381
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT